Yu Y - Search Results

1

Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer.

Meng F, Sun G, Zhong M, Yu Y, Brewer MA. Meng F, et al. Among authors: yu y. Br J Cancer. 2013 Feb 19;108(3):579-86. doi: 10.1038/bjc.2013.10. Epub 2013 Jan 31. Br J Cancer. 2013. PMID: 23370212 Free PMC article.

2

[Medium-chain acyl-CoA dehydrogenase enhances invasion and metastasis ability of breast cancer cells].

Yu Y, Zhao L, Li R. Yu Y, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2019 Jun 30;39(6):650-656. doi: 10.12122/j.issn.1673-4254.2019.06.04. Nan Fang Yi Ke Da Xue Xue Bao. 2019. PMID: 31270042 Free PMC article. Chinese.

3

Wentilactone A Reverses the NF-κB/ECM1 Signaling-Induced Cisplatin Resistance through Inhibition of IKK/IκB in Ovarian Cancer Cells.

Lv C, Ren C, Yu Y, Yin H, Huang C, Yang G, Hong Y. Lv C, et al. Among authors: yu y. Nutrients. 2022 Sep 14;14(18):3790. doi: 10.3390/nu14183790. Nutrients. 2022. PMID: 36145166 Free PMC article.

4

SHP-1 acts as a tumor suppressor by interacting with EGFR and predicts the prognosis of human breast cancer.

Geng Q, Xian R, Yu Y, Chen F, Li R. Geng Q, et al. Among authors: yu y. Cancer Biol Med. 2021 Oct 1;19(4):468-85. doi: 10.20892/j.issn.2095-3941.2020.0501. Online ahead of print. Cancer Biol Med. 2021. PMID: 34591414 Free PMC article.

5

Remodeling of tumor microenvironment by extracellular matrix protein 1a differentially regulates ovarian cancer metastasis.

Yu Y, Lyu C, Li X, Yang L, Wang J, Li H, Xin Z, Xu X, Ren C, Yang G. Yu Y, et al. Cancer Lett. 2024 Aug 1;596:217022. doi: 10.1016/j.canlet.2024.217022. Epub 2024 Jun 5. Cancer Lett. 2024. PMID: 38849014

6

ASS1 enhances anoikis resistance via AMPK/CPT1A-mediated fatty acid metabolism in ovarian cancer.

Feng X, Ji Z, Fan X, Kong Y, Yu Y, Shao Y, Meng J, Zhou X, Tang R, Ren C, Yang G. Feng X, et al. Among authors: yu y. Cancer Lett. 2024 Jun 22:217082. doi: 10.1016/j.canlet.2024.217082. Online ahead of print. Cancer Lett. 2024. PMID: 38914306

7

Extracellular matrix protein-1 secretory isoform promotes ovarian cancer through increasing alternative mRNA splicing and stemness.

Yin H, Wang J, Li H, Yu Y, Wang X, Lu L, Lv C, Chang B, Jin W, Guo W, Ren C, Yang G. Yin H, et al. Among authors: yu y. Nat Commun. 2021 Jul 9;12(1):4230. doi: 10.1038/s41467-021-24315-1. Nat Commun. 2021. PMID: 34244494 Free PMC article.

8

Genetic Variants miR-126, miR-146a, miR-196a2, and miR-499 in Polycystic Ovary Syndrome.

Li R, Yu Y, Jaafar SO, Baghchi B, Farsimadan M, Arabipour I, Vaziri H. Li R, et al. Among authors: yu y. Br J Biomed Sci. 2022 Jan 7;79:10209. doi: 10.3389/bjbs.2021.10209. eCollection 2022. Br J Biomed Sci. 2022. PMID: 35996522 Free PMC article.

9

Combining single-cell analysis and molecular docking techniques to construct a prognostic model for colon adenocarcinoma and uncovering inhibin subunit βb as a novel therapeutic target.

Wu Q, Ye L, Wu Y, Zhao M, Lu J, Yu Y, Niu Y, Zhang L, Zuo P. Wu Q, et al. Among authors: yu y. Front Immunol. 2025 Jan 9;15:1524560. doi: 10.3389/fimmu.2024.1524560. eCollection 2024. Front Immunol. 2025. PMID: 39850875 Free PMC article.

10

Therapeutic effect of low-dose BMSCs-Loaded 3D microscaffold on early osteonecrosis of the femoral head.

Guo M, Qi B, Pei Z, Ni H, Ren J, Luo H, Shi H, Meng C, Yu Y, Tang Z, Xu Y, Xue Q, Li C. Guo M, et al. Among authors: yu y. Mater Today Bio. 2024 Dec 24;30:101426. doi: 10.1016/j.mtbio.2024.101426. eCollection 2025 Feb. Mater Today Bio. 2024. PMID: 39850243 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,432 results

Search Page

Filters